Literatuur

Alivuotila L, Hakokari J, Visnapuu V, Korpijaakko-Huuhka A-M, Aaltonen O, Happonen R-P, Peltonen S, Peltonen J (2010) Speech characteristics in neurofibromatosis type 1. American Journal of Medical Genetics Part A 152A: 42-51

Boyd KP, Korf BR, Theos A (2009) Neurofibromatosis type 1. Journal of the American Academy of Dermatology 61: 1-16

DeBella K, Szudek J, Friedman JM (2000) Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 105: 608-614

Descheemaeker M-J, Ghesquière P, Symons H, Fryns JP, Legius E (2005) Behavioural, academic and neuropsychological profile of normally gifted neurofibromatosis type 1 children. Journal of Intellectual Disability Research 49 part 1, 33-46

Evans DG (2009) Neurofibromatosis type 2: a clinical and molecular review. Orphanet Journal of Rare Diseases. 19: 4-16

Evers A, Resing W (2007) Het drijfzand van didactische leeftijdsequivalenten. De Psycholoog 42: 466-472

Ferner RE, Huson SM, Thomas N, Moss C, Wilshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. Review. Journal of Medical Genetics 44: 81-88

Gilboa Y, Josman N, Fattal-Valevski A, Toledano-Alhadef, Rosenblum S (2010) The handwriting performance of children with NF1. Research in Developmental Disabilities 31: 929-935

Huson SM, Korf BR (2002) The phakomatoses. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR, Emery ALH (2002) Emery and Rimoin’s Principles & Practice of Medical Genetics 4th edition, volume 3, NewYork: Churchill Livingstone pp 3162-3202

Hyman SL, Shores A, North KN (2005) The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 65: 1037-1044

Jennekens-Schinkel A, Jennekens FGI (2008) Neuropsychologie van neurologische aandoeningen in de kindertijd. Amsterdam: Uitgeverij Boom, Hoofdstuk 12, pp 487-512

Johnson H, Wiggs L, Stores G, Huson SM (2005) Psychological disturbance and sleep disorders in children with neurofibromatosis type 1. Developmental Medicine &Child Neurology 47: 237-242

Krab LC, Aarsen FK, de Goede-Bolder A, Catsman-Berrevoets CE, Arts WF, Moll HA, Elgersma Y (2008) Impact of neurofibromatosis type 1 on school performance. Journal of Child Neurology 23: 1002-1010

Krab, LC, de Goede-Bolder A, Aarsen FK, Catsman-Berrevoets CE (2009) Leer- en gedragsstoornissen bij kinderen met neurofibromatose type 1. Brochure gemaakt in opdracht van de Neurofibromatose Vereniging Nederland.

Krab LC, de Goede-Bolder A, Aarsen FK, Moll HA, de Zeeuw CI, Elgersma Y, van der Geest JN (2011) Motor learning in children with neurofibromatosis type 1. Cerebellum 10: 14-21

Lammert M, Friedman JM, Kluwer L, Mautner VF (2005) Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Archives of Dermatology 141: 78-79

McKeever K, Shepherd CW, Crawford H, Morrison PJ (2008) An epidemiological, clinical and genetic survey of neurofibromatosis type 1 in children under sixteen years of age. Ulster Medical Journal 77: 160-163

Pasmant E, Masliah-Planchon J, Lévy P, Laurendeau I, Ortonne N, Parfait B, Valeyrie-Allanore L, Leroy K, Wolkenstein P, Vidaud M, Vidaud D, Bièche I (2011) Identification of genes potentially involved in the increased risk of malignancy in NF1-microdeleted patients. Molecular Medicine 17: 79-87

Payne JM, Hyman SL, Shores EA, North KN (2011) Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior. Child Neuropsychology 1:1-17

Payne JM, Moharir MD, Webster R, North KN (2010) Brain structure and function in neurofibromatosis type 1: current concepts and future directions. Journal of Neurology, Neurosurgery and Psychiatry 81: 304-309

Sabbagh A, Pasmant E, Laurendeau I, Parfait B, Barbarot S, Guillot B, Combemale P, Ferkal S, Videaud M, Aubourg P, Vidaud D, Wolkenstein P and members of the NF France network (2009) Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1. Human Molecular Genetics 18: 2768-2778

Thompson HL, Viskochil DH, Stevenson DA, Chapman KL (2010) Speech−language characteristics of children with neurofibromatosis type 1. American Journal of Medical Genetics Part A 152A: 284-290

Van Engelen SJ, Krab LC, Moll HA, de Goede-Bolder A, Pluijm SM, Catsman-Berrevoets CE, Elgersma Y, Lequin MH (2008) Quantitative differentiation between healthy and disordered brain matter in patients with neurofibromatosis type 1 using diffusion tensor imaging. American Journal of Neuroradiology 29: 816-822